A Single Center, Randomized, Open Label, Multiple Dose, Crossover Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients With Stable Coronary Artery Disease
Phase of Trial: Phase IV
Latest Information Update: 08 May 2015
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 04 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.